The qualitative research study conducted by HTF market Intelligence Consulting Private Limited, USA titled “Global Biocompatibility Testing Services Market Size, Status and Forecast 2025” has featured Ahmedabad based Contract Research Organisation (CRO) Accuprec Research Labs Pvt. Ltd. as a Key Player in the Global Business Report. Biocompatibility testing services deals with a set of guidelines and testing parameters used for evaluation of medical device or any compounds safety before coming to the market. The testing services ranges from initial screening of new materials to product release testing and non-clinical or pre-market safety evaluations.
The research study is segmented by Types [Material/Chemical Characterization, Cytotoxicity, Hemocompatibility, Implantation Testing, Irritation / Intracutaneous Reactivity, Sensitization, Systemic Toxicity, Pyrogenicity & USP Plastics (USP Class VI] as well as Key Applications [Initial screening of new materials, Product release testing & Pre-market safety evaluations] with historical and projected market share along with the growth rate, revenue figures and gross profit margin in tabular format which makes easy to understand product/service differences, market concentration rate and product distribution for past 5 years.
“Major geographical regions like United States, Europe, China, Japan, Southeast Asia & India and leading players such as Wickham Laboratories, North American Science Associates, Accuprec Research Labs, Nelson Laboratories, Toxikon, Pacific BioLabs, BioComp Laboratories & Geneva Laboratories involved in this report. The report gives a clear idea about the growth factors, reasons for deterioration of Global Biocompatibility Testing Services in recent years and different opportunities and strategies to expand market”, the Report adds.
Dr. Manish Rachchh, Director (R & D) & CEO of Accuprec Research Labs Pvt. Ltd. said that Increasing spending in preclinical phase of medical devices coupled with growing outsourcing rate is anticipated to help the market gain significant traction. Surging demand for in-vitro test is also projected to fuel demand for testing services as many CROs are developing novel in-vitro methods to replace traditional in-vivo methods, which require animal testing. Improvements in procedures for development and standardization of novel in vitro test methods, particularly for sensitization, cytotoxicity, and irritation, are also working in favor of the market. There has been a significant increase in preclinical spending for both pharmaceutical and medical devices. This trend is estimated to contribute to the demand for testing services by medical device companies.
About Accuprec:
Accuprec Research Labs Pvt. Ltd. is the NABL Accredited Contract Research Organisation (CRO) of Gujarat providing services in 14 verticals under One roof. The CRO is a service provider for various testing services required for pharmaceuticals, chemicals and phytochemicals as well as herbal formulations. Accuprec has been founded by a group of highly qualified professionals and academicians having excellent track record with proven success and commitment to quality in their respective areas of expertise. Accuprec has developed so far 11 patented poly herbal formulations for various chronic diseases like Diabetes, Obesity, Rhematoid Arthritis, Liver diseases, Osteoarthritis etc. Innovative Lipstick created by the Accuprec achieved Gujarat Innovation Society Award recently.
Coverage in Media:
